Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow up study

British Medical Journal

Volumn 313, Issue 7057, 1996, Pages 591-594

  Parving, Hans Henrik ^a   Jacobsen, Peter ^a   Tarnow, Lise ^a   Rossing, Peter ^a   Lecerf, Laure ^b   Poirier, Odette ^b   Cambien, François ^b  

^a STENO DIABETES CENTER   (Denmark)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTERIAL PRESSURE; ARTICLE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS;

EID: 0029830688     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7057.591     Document Type: Article

References (23)

1. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-80.
2. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. In: Brenner BM, ed. The kidney. Philadelphia: Saunders, 1996:1864-92.
3. Erdos EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
4. Marre M, Chatellier G, Leblanc H, Guyenne T-T, Ménard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-5.
5. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 1991;303:81-7.
6. Viberti GC, Mogensen CE, Groop L, Pauls JF, European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-9.
7. Parving H-H, Hommel E, Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 1988;297:1086-91.
8. Björck S, Muleç H, Johnsen SA, Nordén G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992;304:339-43.
9. Lewis E, Hunsicker L, Bain R, Rhode R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
10. Parving H-H, Rossing P, Hommel E, Smidt UM. Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis 1995;26:99-107.
11. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162-9.
12. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RSC, et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995;345:1540-2.
13. Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;i:1175-9.
14. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995;44:489-94.
15. Bröchner-Mortensen J, Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976;36:35-45.
16. Miles DW, Mogensen CE, Gundersen HJG. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 1970;26:5-11.
17. Bröchner-Mortensen J. Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 1985;5:1-17.
18. Modification of Diet in Renal Disease Study Group, Levey AS, Gassman J, Hall PM, Walker WG. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1991;1:1087-94.
19. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996;347:94-5.
20. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981;20:457-61.
21. Rossing P, Hommel E, Smidt UM, Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993;42:715-9.
22. Breyer JA, McGill JB, Nahman NS. Predictors of the rate of progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. J Am Soc Nephrol 1993;4:301.
23. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-9.